Re: CASH
|
7
|
Resverlogix Corp.
|
Oct 05, 2019 04:24AM
|
Re: CASH
|
3
|
Resverlogix Corp.
|
Oct 05, 2019 11:55AM
|
Re: CASH
|
5
|
Resverlogix Corp.
|
Oct 05, 2019 12:14PM
|
Re: CASH
|
2
|
Resverlogix Corp.
|
Oct 05, 2019 12:18PM
|
Re: CASH
|
3
|
Resverlogix Corp.
|
Oct 05, 2019 01:33PM
|
Re: CASH
|
2
|
Resverlogix Corp.
|
Oct 05, 2019 03:48PM
|
Re: CASH
|
3
|
Resverlogix Corp.
|
Oct 05, 2019 04:07PM
|
Re: CBC Radio News Interview with Dr. Sweeney
|
3
|
Resverlogix Corp.
|
Feb 01, 2022 01:55PM
|
Re: Change in Auditors
|
5
|
Resverlogix Corp.
|
Mar 08, 2023 11:41AM
|
Re: Chart showing the convergence of the 50 & 200 DMAs....
|
3
|
Resverlogix Corp.
|
Mar 09, 2019 10:37PM
|
Re: Checking the chart and seeing another pennant, contractions coming quicker....
|
1
|
Resverlogix Corp.
|
May 13, 2019 12:38PM
|
Re: CityNews cover
|
6
|
Resverlogix Corp.
|
Jan 31, 2022 01:32PM
|
Re: Classifying/taxonomy mCRPC patients
|
5
|
Zenith Epigenetics
|
Apr 20, 2019 06:53PM
|
Re: Close competitor…
|
6
|
Resverlogix Corp.
|
Oct 19, 2021 04:29PM
|
Re: Code of Conduct
|
1
|
Resverlogix Corp.
|
Sep 12, 2019 04:17PM
|
Re: coldn brought this up on the rvx board...
|
3
|
Zenith Epigenetics
|
May 13, 2019 11:05PM
|
Re: Compensation
|
2
|
Resverlogix Corp.
|
May 21, 2022 01:39PM
|
Re: Connecting the Dots II - Royalty Preferred Shares
|
3
|
Resverlogix Corp.
|
Feb 17, 2019 01:17PM
|
Re: Convertible Debenture
|
3
|
Zenith Epigenetics
|
May 30, 2020 12:07PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
10
|
Resverlogix Corp.
|
Dec 16, 2021 01:14PM
|